期刊文献+

非透析终末期尿毒症患者血清对外周血单个核细胞IL-18分泌的影响

Effects of ESRD non-dialysed patients's serum on secretion of IL-18 in peripheral blood mononuclear cells
下载PDF
导出
摘要 目的探讨非透析终末期尿毒症(ESRD)患者混合血清及不同分子质量血清对外周血单个核细胞(PBMCs)、白细胞介素18(IL-18)分泌的影响。方法分离非透析ESRD患者混合血清,采用超滤离心装置分离非透析ESRD患者不同分子质量血清,同时用Ficoll密度梯度离心分离14例非透析ESRD患者PBMCs,将非透析ESRD患者不同分子质量的血清与非透析ESRD患者PBMCs,共同培养72h,用酶联免疫吸附分析(ELISA)检测试验对象的血清和培养上清液中IL-18浓度。结果 (1)非透析ESRD患者外周血IL-18含量显著高于对照组,差异有统计学意义P<0.001);(2)非透析ESRD患者大分子质量血清刺激同源PBMCs分泌IL-18较高,差异有统计学意义(P<0.05)。结论分子质量大于10000U的尿毒症毒素是刺激PBMCs引起IL-18分泌增加的主要毒素,提示大分子质量尿毒症毒素可能是导致非透析ESRD患者微炎性反应状态的独立危险因素。 Objective To investigated the effects of different molecular weight serum of end stage renal disease(ESRD)non-dialysed patients on the production of IL-18 in peripheral blood mononuclear cells(PBMCs).Methods PBMCs from 14 ESRD non-dialysed patients were isolated by the density gradient centrifugation and cultured with different molecular weight sera from uremic patients for 72 h.The levels of IL-18 in serum and supernatant were evaluated by enzyme-linked immunosorbent assay(ELISA).Results(1)Serum IL-18 level in ESRD non-dialysed patients was significantly higher than that of the controls[(564.74±285.19)pg/mL vs(100.40±73.20)pg/mL,P〈0.001];(2)After incubation with different molecular weight of uremic serum,the secretion of IL-18 in PBMCs was significantly higher in molecular weight〉 10 000 D group(P〈0.05).Conclusion The uremic toxin with molecular weight 〉10000D is the main toxin to promote the prodution of IL-18 in PBMCs,which may be an independent risk factor of ESRD non-dialysed patients's microinflammatory state.
出处 《检验医学与临床》 CAS 2010年第20期2226-2227,共2页 Laboratory Medicine and Clinic
关键词 尿毒症血清 外周血单个核细胞 白细胞介素18 uremic serum PBMCs IL-18
  • 相关文献

参考文献9

  • 1Puren AJ,Fantuzzi G,Gu Y,et al.Interleukin-18 and IL-1 beta via TNFalpha production from non-CD14+ human blood mononuclear cells[J].J Clin Invest,1998,101(3):711-721.
  • 2许勇芝,唐德燊,梁东,江黎明,刘华锋,刘海燕,陈孝文.慢性肾衰患者外周血IL-18水平及血液透析对其的影响[J].上海免疫学杂志,2003,23(1):50-52. 被引量:16
  • 3Uchimura T,Motomiya Y,Okamura H,et al.Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients:compara tive study of advanced glycation end products[J].Carboxymethyl Pentosidine Nephron,2002,90(4):401-407.
  • 4陈婷,陈孝文,唐德燊,江黎明,梁东,刘华锋.尿毒症血清对外周血单个核细胞IL-18表达及分泌水平的影响[J].中国中西医结合肾病杂志,2003,4(11):629-632. 被引量:1
  • 5Rampino T,Libetta C,De-Simone W,et al.Hemodialysis stimulates hepatocyte growth factor release[J].Kidney Int,1998,53(5):1382-1388.
  • 6Okamura H,Tsutsui H,Komatsu T,et al.Cloning of a new cytokine that induces IFN gamma production by T cells[J].Nature,1995,378(6552):88-91.
  • 7Leung BP,Culshaw S,Gracie JA,et al.A role for IL-18 in neutrophil activation[J].J Immunol,2001,167:2879-2886.
  • 8Beerenhout CH,Luik AJ,Jeuken-Mertens SG,et al.Pre-dilution on-line hemofiltration vs low-flux hemodialysis:a randomized prospective study[J].Nephrol Dial Transplant,2005,20(6):1155-1163.
  • 9Van Tellingen A,Schalkwijk CG,Teerlink T,et al.Influence of different hemodialysis modalities on AGE peptide levels:intradialytic versus long-term results[J].Nephron Clin Pract,2005,100(1):5-7.

二级参考文献11

  • 1Pertosa G, Grandaliano G, Gesualdo L, et al. Clinical relevance of cytokine production in hemodialysis[J]. Kid Int ,2000,58:76s104.
  • 2proinflammatory role for IL-18 in rheumatoid arthritis[J]. J Clin Invest, 1999,104:1393.
  • 3Monteleone G, Trapasso F, Parrello T, et al. Bioactive IL- 18 expression is up-regulated in Crohn's disease[J]. J Immunol, 1999,163:143.
  • 4Kodama T, Matsuyama T, Kuribayashi K, et al. IL-18 deficiency selec-tively enhances allergen-induced eosinophilia in mlce[J]. J Allergy Clin Immunol, 2000, 105 : 45.
  • 5Rothe H, Hausmann A, Casteels K, et al. IL- 18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis[J]. J Immunol, 1999,163: 1230.
  • 6Netea MG, Fantuzzi G, Kullberg BJ, et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia[J]. J Immunol, 2000,164 : 2644.
  • 7Kikuchi T, Akasaki Y, Joki T, et al. Antitumor activity of interleukin-18 on mouse glioma cells[J]. J Immunother, 2000,23 : 184.
  • 8Yamaguchi T, Iwano M, Kubo A, et al. IL-6 mRNA synthesis by peripheral blood mononuclear cells (PBMC) in patients with chronic renal failure[J]. Clin Exp Immunol, 1996,103:279.
  • 9Tzanatos HA, Agroyannis B, Chondros C, et al. Cytokine release and serum lipoprotein (a) alterations during hemodialysis [J]. Artif Organs, 2000,24 : 329.
  • 10侯凡凡,张训.慢性肾功能衰竭时晚期糖基化终产物的病理生理[J].中华肾脏病杂志,1997,13(5):312-314. 被引量:16

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部